Security key
G7709Q104
Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX)
CUSIP: G7709Q104
Q4 2021 13F Holders as of 31 Dec 2021
- Security type / class
- Equity / Class A Ordinary Shares, par value $0.0001 per share
- Total 13F shares
- 268,200,640
- Total 13F value
- $10,687,984,091
- Share change
- +3,377,339
- Put/Call ratio
- 20%
- SEC-reported price per share
- $39.85
- Number of holders
- 254
- Value change
- +$139,946,049
- Number of buys
- 153
- Number of sells
- 88
- Shares outstanding
- 445,144,313
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2021
Institutions
254
Top holders
10
RPRX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2022
Previous quarter: Q3 2021
Royalty Pharma plc SEC filings
Royalty Pharma plc company facts
Broader feeds
Reporting periods
Holder history for CUSIP G7709Q104
Recent filing periods:
Ownership snapshot
Top reported holders of RPRX - Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
MORGAN STANLEY
Disclosed value leader
MORGAN STANLEY
Comparable rows
15/15
Latest evidence
30 Sep 2021
13F
Lead comparable stake: 13%
Showing 1-6 of 15 holder rows.
Quick read
MORGAN STANLEY leads the comparable SEC ownership view at 13%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens MORGAN STANLEY's linked filing trail.
Comparable ownership
Top 5
MORGAN STANLEY
13%
VANGUARD GROUP INC
6.7%
ADAGE CAPITAL PARTNERS GP, L.L.C.
5.5%
FMR LLC
4.3%
BlackRock Finance, Inc.
3.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MORGAN STANLEY |
13F
Company
|
13%
|
$2,071,013,000
57,305,311 shares
|
— | 30 Sep 2021 |
| VANGUARD GROUP INC |
13F
Company
|
6.7%
|
$1,085,216,000
30,028,062 shares
|
— | 30 Sep 2021 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
Company
|
5.5%
|
$892,579,000
24,697,815 shares
|
— | 30 Sep 2021 |
| FMR LLC |
13F
Company
|
4.3%
|
$690,627,000
19,109,751 shares
|
— | 30 Sep 2021 |
| BlackRock Finance, Inc. |
13F
Company
|
3.5%
|
$558,754,000
15,460,845 shares
|
— | 30 Sep 2021 |
| BERKSHIRE HATHAWAY INC |
13F
Company
|
3%
|
$475,093,000
13,145,902 shares
|
— | 30 Sep 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
254
Shares
268,200,640
Rows available
254
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
226
Q4 2021 holders
254
Holder diff
28
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 value | Q4 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend